Ja. Chorny et al., IMMUNOHISTOCHEMICAL STUDY OF THE RETINOIC ACID RECEPTOR-ALPHA IN NORMAL VERSUS NEOPLASTIC HUMAN TISSUES, Applied immunohistochemistry, 3(1), 1995, pp. 64-71
The molecular basis of transcription regulation by retinoic acid recep
tors (RARs) has been well studied, but the histologic distribution of
these receptors in normal and neoplastic human tissues is not well def
ined, despite the frequent use of retinoic acid in medicine. We descri
be here the microanatomical distribution of RAR alpha in such tissues
and discuss its biologic implications. A monoclonal antibody directed
against the RAR alpha protein was used in an alkaline phosphatase anti
-alkaline phosphatase (APAAP) technique applied to frozen sections of
benign and neoplastic human tissues. Staining was confined to the nucl
eus except among glial tissues where there was intense, focal cytoplas
mic staining, RAR alpha expression was nearly absent in mitotically ac
tive benign cell populations but was strongly expressed in populations
undergoing terminal differentiation. Nonproliferating, long-lived cel
ls such as neurons, myocytes, chondrocytes, and hepatocytes had little
to no expression of this receptor. Among the malignant tumors there w
as marked variability of nuclear staining intensity. Lung carcinomas w
ere strongly labelled, while nuclear staining in glial tumors was weak
, although there was intense, focal cytoplasmic staining. In contrast
to benign tissues, RAR alpha expression paradoxically correlated with
the amount of cellular proliferation as determined by immunostaining w
ith the Ki67 monoclonal antibody among lung tumors, and by mitotic rat
es among all of the tumors studied. These results suggest that RAR alp
ha plays a role in controlling cellular proliferation and terminal dif
ferentiation in benign tissues and that this regulation is markedly al
tered in the malignant tissues that were examined.